A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder

Bipolar Disorders

Volumn 12, Issue 3, 2010, Pages 230-243

  Vieta, Eduard ^a   Nuamah, Isaac F ^b   Lim, Pilar ^b   Yuen, Eric C ^b   Palumbo, Joseph M ^b   Hough, David W ^b   Berwaerts, Joris ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Bipolar I disorder; Mania; Paliperidone ER; Quetiapine

Indexed keywords

ANTIHISTAMINIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DIAZEPAM; LORAZEPAM; PALIPERIDONE; PLACEBO; QUETIAPINE; DIBENZOTHIAZEPINE DERIVATIVE; ISOXAZOLE DERIVATIVE; NEUROLEPTIC AGENT; PYRIMIDINE DERIVATIVE;

ACUTE MANIA; ADULT; AGED; AGITATION; AKATHISIA; ARTICLE; BIPOLAR I DISORDER; BODY WEIGHT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; ELECTROCARDIOGRAM; EXTENDED RELEASE TABLET; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; GLOBAL ASSESSMENT OF FUNCTIONING SCORE; HUMAN; HYPERSALIVATION; INCREASED APPETITE; INSOMNIA; LETHARGY; MAINTENANCE THERAPY; MAJOR DEPRESSION; MALE; MANIA; MIXED MANIA AND DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; MUSCLE HYPERTONIA; MUSCLE SPASM; MYALGIA; NAUSEA; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; REBOUND; REMISSION; SCORING SYSTEM; SEDATION; SIDE EFFECT; SOMNOLENCE; SUICIDAL IDEATION; SUICIDE; TABLET FORMULATION; TACHYCARDIA; TARDIVE DYSKINESIA; TOOTH PAIN; TREATMENT DURATION; TREMOR; VITAL SIGN; XEROSTOMIA; YOUNG MANIA RATING SCALE; BIPOLAR DISORDER; CLASSIFICATION; FOLLOW UP; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PYRIMIDINES; TREATMENT OUTCOME;

EID: 77953921629     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2010.00815.x     Document Type: Article

References (37)

1. Kastrup MC, Ramos AB. Global mental health. Dan Med Bull 2007, 54:42-43.
2. Rush AJ. Toward an understanding of bipolar disorder and its origin. J Clin Psychiatry 2003, 64(Suppl. 6):4-8.
3. Rosa AR, Franco C, Martinez-Aran A. Functional impairment in patients with remitted bipolar disorder. Psychother Psychosom 2008, 77:390-392.
4. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002, 159:1-50.
5. Vieta E, Goikolea JM. Atypical antipsychotics: newer options for mania and maintenance therapy. Bipolar Disord 2005, 7:21-33.
6. Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv 2007, 58:855-863.
7. Fountoulakis KN, Vieta E, Siamouli M. Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder. Ann Gen Psychiatry 2007, 6:27.
8. Conley R, Gupta SK, Sathyan G. Clinical spectrum of the osmotic-controlled release oral delivery system (OROS®), an advanced oral delivery form. Curr Med Res Opin 2006, 22:1879-1892.
9. Owen RT. Extended-release paliperidone: efficacy, safety and tolerability profile of a new atypical antipsychotic. Drugs Today 2007, 43:249-258.
10. Lautenschlager M, Heinz A. Paliperidone-ER: first atypical antipsychotic with oral extended release formulation. Expert Rev Neurother 2008, 8:193-200.
11. Kane J, Canas F, Kramer M. Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial. Schizophr Res 2007, 90:147-161.
12. Marder SR, Kramer M, Ford L. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study. Biol Psychiatry 2007, 62:1363-1370.
13. Davidson M, Emsley R, Kramer M. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study. Schizophr Res 2007, 93:117-130.
14. Kramer M, Simpson G, Maciulis V. Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2007, 27:6-14.
15. Emsley R, Berwaerts J, Eerdekens M. Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies. Int Clin Psychopharmacol 2008, 23:343-356.
16. Diagnostic and Statistical Manual of Mental Disorders 2000, 4th edition ed, Washington, DC, American Psychiatric Association
17. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435.
18. Seroquel Prescribing Information. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM191896.pdf, Last accessed April 6, 2010
19. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997, 73:159-171.
20. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
21. A study to evaluate the efficacy and safety of flexible doses of extended-release (ER) paliperidone compared with flexible doses of quetiapine and placebo in patients with bipolar I disorder. http://www.clinicaltrials.gov/ct2/show/NCT00309699?term=paliperidone+ER+bipolar&rank=3, Last accessed April 1, 2010
22. Guy W. AIMS. Abnormal Involuntary Movement Scale. ECDEU Assessment for Psychopharmacology 1976, 534-537. revised edition, Rockville, MD, National Institute of Mental Health
23. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989, 154:672-676.
24. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970, 212:11-19.
25. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
26. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979, 47:343-352.
27. Westfall PTR, Rom D, Wolfinger RD, Hochberg Y. Multiple Comparisons and Multiple Tests Using SAS 1999, eds, Cary, NC, SAS Institute, Inc.
28. Martinez-Aran A, Vieta E, Chengappa KNR, Gershon S, Mullen J, Paulsson B. Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change. Bipolar Disord 2008, 10:566-579.
29. Vieta E, Carne X. The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate. Psychother Psychosom 2005, 74:10-16.
30. Keck PE, Welge JA, McElroy SL, Arnold LM, Strakowski SM. Placebo effect in randomized, controlled studies of acute bipolar mania and depression. Biol Psychiatry 2000, 47:748-755.
31. Bowden CL, Grunze H, Mullen J. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005, 66:111-121.
32. McIntyre RS, Brecher M, Paulsson B, Huizar K, Mullen J. Quetiapine or haloperidol as monotherapy for bipolar mania-a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 2005, 15:573-585.
33. Derry S, Moore RA. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials. BMC Psychiatry 2007, 7:40.
34. Storosum JG, Wohlfarth T, Schene A, Elferink A, van Zwieten BJ, van den Brink W. Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode. Bipolar Disord 2007, 9:793-798.
35. Young AH, Oren DA, Lowy A. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. Br J Psychiatry 2009, 194:40-48.
36. Keck PE, Orsulak PJ, Cutler AJ. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. J Affect Disord 2009, 112:36-49.
37. Torrent C, Amann B, Sanchez-Moreno J. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. Acta Psychiatr Scand 2008, 118:4-18.